5593-20-4

  • Product Name:Betamethasone Dipropionate
  • Molecular Formula:C28H37FO7
  • Purity:99%
  • Molecular Weight:504.596
Inquiry

Product Details;

CasNo: 5593-20-4

Molecular Formula: C28H37FO7

Appearance: Powder

Manufacturer supply good quality Betamethasone Dipropionate 5593-20-4 with stock

  • Molecular Formula:C28H37FO7
  • Molecular Weight:504.596
  • Appearance/Colour:Powder 
  • Vapor Pressure:3.97E-18mmHg at 25°C 
  • Melting Point:178 °C 
  • Refractive Index:69 ° (C=1, Dioxane) 
  • Boiling Point:603.2 °C at 760 mmHg 
  • PKA:12.87±0.70(Predicted) 
  • Flash Point:318.6 °C 
  • PSA:106.97000 
  • Density:1.24 g/cm3 
  • LogP:3.81750 

Betamethasone 17,21-dipropionate(Cas 5593-20-4) Usage

Manufacturing Process

A solution of 9α-fluoro-11β-hydroxy-16β-methyl-17α,21-(1'-ethyl-1'- ethoxymethylenedioxy)pregna-1,4-diene-3,20-dione (538 mg) in acetic acid (20 ml), containing 2 drops of water, was allowed to stand at room temperature for 5 hours. Dilution of the mixture with water gave a white solid (457 mg) which, after being filtered off and dried, was recrystallized from acetone to afford 9α-fluoro-11β,21-dihydroxy-16β-methyl-17α- propionyloxypregna-1,4-diene-3, 20-dione (361 mg), MP 230°-235°C. Bethmethasone 17-propionate (812 mg) in pyridine (10 ml) was treated with propionyl chloride (0.21 ml) at 0°C for 1 hour. Dilution with water and acidification with dilute hydrochloric acid gave the crude diester. Recrystallization from acetone-petroleum ether afforded betamethasone 17,21-dipropionate (649 mg), MP 117°C (decomposition).

Therapeutic Function

Glucocorticoid

Biochem/physiol Actions

Betamethasone 17,21-dipropionate is a glucocorticoid with anti-inflammatory and immunosuppressive activity.

Safety Profile

Poison by subcutaneous andintraperitoneal routes. An experimental teratogen. Otherexperimental reproductive effects. When heated todecomposition it emits toxic fumes of F-.

Definition

Betamethasone 17,21-dipropionate is a steroid ester that is betamethasone in which the hydroxy hydrogens at positions 17 and 21 are replaced by propanoyl groups. It is used in combination with calcipotriene hydrate, a synthetic vitamin D analogue, for the topical treatment of plaque psoriasi in adult patients.

Brand name

Alphatrex (Savage); Diprolene (Schering).

InChI:InChI=1/C27H34ClFO7/c1-5-22(33)35-14-21(32)27(36-23(34)13-28)15(2)10-19-18-7-6-16-11-17(30)8-9-24(16,3)26(18,29)20(31)12-25(19,27)4/h8-9,11,15,18-20,31H,5-7,10,12-14H2,1-4H3/t15-,18-,19-,20-,24-,25-,26?,27-/m0/s1

5593-20-4 Relevant articles

Preparation method of betamethasone dipropionate

-

Paragraph 0009; 0044-0062, (2021/05/29)

The invention belongs to the technical f...

Preparation method of betamethasone 17 alpha-propionate

-

Paragraph 0011; 0012; 0013; 0014; 0015; 0016; 0018, (2019/08/20)

The invention provides a preparation met...

Pharmaceutical composition

-

, (2008/06/13)

A pharmaceutical composition for dermal ...

Composition for the topical treatment of poison ivy and other forms of contact dermatitis

-

, (2008/06/13)

Composition for topical administration c...

5593-20-4 Process route

Betamethasone propionate
5534-13-4

Betamethasone propionate

propionic acid anhydride
123-62-6

propionic acid anhydride

betamethasone dipropionate
5593-20-4

betamethasone dipropionate

Conditions
Conditions Yield
With dmap; In dichloromethane; at 0 - 10 ℃; Reagent/catalyst; Solvent; Temperature; Inert atmosphere; Large scale;
96%
Betamethasone propionate
5534-13-4

Betamethasone propionate

betamethasone dipropionate
5593-20-4

betamethasone dipropionate

Conditions
Conditions Yield
In tetrahydrofuran; water; at 50 - 80 ℃; for 8h; under 450.045 Torr;

5593-20-4 Upstream products

  • 378-44-9
    378-44-9

    betamethasone

  • 5534-13-4
    5534-13-4

    Betamethasone propionate

  • 123-62-6
    123-62-6

    propionic acid anhydride

5593-20-4 Downstream products

  • 378-44-9
    378-44-9

    betamethasone

  • 5534-13-4
    5534-13-4

    Betamethasone propionate

  • 72559-98-9
    72559-98-9

    9α-fluoro-6,11β,17α,21-tetrahydroxy-16β-methyl-1,4,6-pregnatriene-3,20-dione 6-benzoate 17,21-dipropionate

  • 82926-64-5
    82926-64-5

    9α-fluoro-3,11β,17α,21-tetrahydroxy-16β-methyl-1,3,5-pregnatriene-20-one 3-benzoate 17,21-dipropionate

Relevant Products